This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Amlin | HSBC ups TP to 455p from 435p: Neutral |
| Aviva | HSBC ups TP to 355p from 350p: Neutral |
| Capital and Counti | Cantor Fitzgerald ups TP to 300p from 233p, Hold |
| Catlin Group | HSBC ups TP to 609p from 582p: Neutral |
| Genel Energy | Credit Suisse ups TP to 1246p from 1236p: Outperform |
| Hiscox | HSBC ups TP 540p to 467.8p: Underweight |
| Kenmare Resources | VSA Capital ups TP to 25p from 22.4p: Sell |
| Legal and General | HSBC ups TP to 215p from 195p: Overweight |
| MAN Group | HSBC ups TP to 107p from 94p: Underweight |
| Marks and Spencer | Panmure Gordon ups TP to 516p from 471p: Buy |
| National Grid | JP Morgan Cazenove cuts TP to 735p from 785p: Neutral |
| Prudential | HSBC ups TP to 1385p from 1375p: Overweight |
| Severn Trent | HSBC ups TP to 1860p from 1840p: Underweight |
| Severn Trent | S&P Capital ups TP 1800p from 1600p: Hold |
| Standard Life | HSBC ups TP to 330p from 310p: Underweight |
| Tate & Lyle | Panmure Gordon downgrades to sell from Hold; 750p TP |
| Tate & Lyle | Citigroup ups TP to 1000p from 900p: Buy |
| Tate and Lyle | UBS ups TP to 890p from 830p: Neutral |
| Tate and Lyle | SocGen cuts TP to 955p from 975p: Buy |
| Tullow Oil | Credit Suisse cuts TP to 1270p from 1289p; Neutral |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research